Literature DB >> 21500914

The nicotinic acetylcholine receptor gene CHRNA4 is associated with negative emotionality.

Sebastian Markett1, Christian Montag, Martin Reuter.   

Abstract

Knock-out studies in mice suggest a role of the CHRNA4 gene in anxiety. In the present study we extend this finding to humans by means of a genetic association study. In a sample of N = 574 healthy White participants, the CHRNA4 rs1044396 polymorphism is related to the common variance of several conceptualizations of negative emotionality. Compared to carriers of at least one T-allele, carriers of the homozygous C/C genotype described themselves as more anxious and emotionally unstable on various psychometric personality questionnaires. The scope of the genetic effect is remarkable because other prominent genetic markers for anxiety show specificity for the diagnostic tool used. The present study is the first study that demonstrates the relevance of the CHRNA4 gene for negative emotionality in humans and sets a starting point for further investigations that could inform on the treatment of various affective psychiatric disorders. PsycINFO Database Record (c) 2011 APA, all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21500914     DOI: 10.1037/a0021784

Source DB:  PubMed          Journal:  Emotion        ISSN: 1528-3542


  8 in total

Review 1.  The role of the catechol-O-methyltransferase (COMT) gene in personality and related psychopathological disorders.

Authors:  Christian Montag; Magdalena Jurkiewicz; Martin Reuter
Journal:  CNS Neurol Disord Drug Targets       Date:  2012-05       Impact factor: 4.388

2.  A novel differential susceptibility gene: CHRNA4 and moderation of the effect of maltreatment on child personality.

Authors:  Rachael G Grazioplene; Colin G Deyoung; Fred A Rogosch; Dante Cicchetti
Journal:  J Child Psychol Psychiatry       Date:  2012-12-13       Impact factor: 8.982

3.  Anxious personality and functional efficiency of the insular-opercular network: A graph-analytic approach to resting-state fMRI.

Authors:  Sebastian Markett; Christian Montag; Martin Melchers; Bernd Weber; Martin Reuter
Journal:  Cogn Affect Behav Neurosci       Date:  2016-12       Impact factor: 3.282

4.  CHRNA4 rs1044396 is associated with smoking cessation in varenicline therapy.

Authors:  Juliana Rocha Santos; Paulo R X Tomaz; Jaqueline S Issa; Tânia O Abe; José E Krieger; Alexandre C Pereira; Paulo C J L Santos
Journal:  Front Genet       Date:  2015-02-27       Impact factor: 4.599

Review 5.  Early Life Stress, Nicotinic Acetylcholine Receptors and Alcohol Use Disorders.

Authors:  Joan Y Holgate; Selena E Bartlett
Journal:  Brain Sci       Date:  2015-06-30

6.  Nicotinergic Modulation of Attention-Related Neural Activity Differentiates Polymorphisms of DRD2 and CHRNA4 Receptor Genes.

Authors:  Thomas P K Breckel; Carsten Giessing; Anja Gieseler; Sarah Querbach; Martin Reuter; Christiane M Thiel
Journal:  PLoS One       Date:  2015-06-16       Impact factor: 3.240

7.  Comparative Assessment of Outcomes in Drug Treatment for Smoking Cessation and Role of Genetic Polymorphisms of Human Nicotinic Acetylcholine Receptor Subunits.

Authors:  Ahmet Muderrisoglu; Elif Babaoglu; Elif Tugce Korkmaz; Said Kalkisim; Erdem Karabulut; Salih Emri; Melih O Babaoglu
Journal:  Front Genet       Date:  2022-02-10       Impact factor: 4.599

8.  Massive withdrawal symptoms and affective vulnerability are associated with variants of the CHRNA4 gene in a subgroup of smokers.

Authors:  Judit Lazary; Peter Dome; Iren Csala; Gabor Kovacs; Gabor Faludi; Mari Kaunisto; Balazs Dome
Journal:  PLoS One       Date:  2014-01-30       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.